•  
  •  
 
The University of Louisville Journal of Respiratory Infections

Abstract

We are in the midst of a pandemic due to SARS-CoV-2. Pregnancy was identified among the risk factors for worse clinical outcomes in multiple studies. The optimal therapy in this group of patients remains to be defined. Here we present the case of a 39 years old Caucasian pregnant female at 31 weeks of gestation who was treated successfully with hydroxychloroquine, azithromycin, remdesivir, prone therapy, and cesarean delivery of a healthy baby while on mechanical ventilation. The SARS-CoV-2 remained positive until the 39th day of hospitalization. We discussed the pathophysiology of the increase risk of infections during pregnancy and particularly the high risk of microthombosis and coagulopathy due to COVID-19. Ultimately the contribution of the medications used to the favorable outcomes remained unknown being more likely that the delivery helped resolve the infection.

Funder

The author(s) received no specific funding for this work.

DOI

10.18297/jri/vol4/iss1/73

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.